» Articles » PMID: 37711052

Podophyllotoxin Reduces the Aggressiveness of Human Oral Squamous Cell Carcinoma Through Myeloid Cell Leukemia‑1

Overview
Journal Int J Mol Med
Specialty Genetics
Date 2023 Sep 15
PMID 37711052
Authors
Affiliations
Soon will be listed here.
Abstract

Podophyllotoxin (PPT), which is derived from the podophyllum plant, exhibits marked cytotoxic effects against cancer cells; however, the precise molecular mechanism underlying its activity against human oral squamous cell carcinoma (OSCC) has not been elucidated. In the present study, the mechanism by which PPT induced cytotoxicity in two OSCC cell lines, HSC3 and HSC4, was determined. The effects of PPT on cytotoxicity in HSC3 and HSC4 cells were analyzed using Annexin V/PI double staining, Sub‑G1 analysis, soft agar assays, western blotting, and quantitative PCR. The changes in the mitochondrial membrane potential were assessed using a JC‑1 assay and cytosolic and mitochondrial fractionation. A myeloid cell leukemia‑1 (Mcl‑1) overexpression cell lines were also established to study the role of Mcl‑1 on apoptosis. The results showed that PPT inhibited the growth of the two human OSCC cell lines and induced apoptosis, which was accompanied by mitochondrial membrane depolarization. Compared with the control, PPT reduced the expression of Mcl‑1 in both cell lines through a proteasome‑dependent protein degradation process. Overall, these results suggested that targeting of Mcl‑1 protein by PPT induced apoptosis, providing a foundation for further pre‑clinical and clinical study of its value in the management of OSCC.

Citing Articles

Cloning and bioinformatics analysis of key gene ShOMT3 of podophyllotoxin biosynthesis pathway in Sinopodophyllum hexandrum.

Liu W, Gao H, Zhao D, Li S, Li L, Zhao X PLoS One. 2025; 20(2):e0314919.

PMID: 39951440 PMC: 11828346. DOI: 10.1371/journal.pone.0314919.


The Effects of Podophyllotoxin Derivatives on Noncancerous Diseases: A Systematic Review.

Strus P, Sadowski K, Ploch W, Jazdzewska A, Oknianska P, Raniszewska O Int J Mol Sci. 2025; 26(3).

PMID: 39940726 PMC: 11816842. DOI: 10.3390/ijms26030958.

References
1.
Xiao J, Gao M, Sun Z, Diao Q, Wang P, Gao F . Recent advances of podophyllotoxin/epipodophyllotoxin hybrids in anticancer activity, mode of action, and structure-activity relationship: An update (2010-2020). Eur J Med Chem. 2020; 208:112830. DOI: 10.1016/j.ejmech.2020.112830. View

2.
Usman S, Jamal A, Teh M, Waseem A . Major Molecular Signaling Pathways in Oral Cancer Associated With Therapeutic Resistance. Front Oral Health. 2022; 1:603160. PMC: 8757854. DOI: 10.3389/froh.2020.603160. View

3.
Wong R . Apoptosis in cancer: from pathogenesis to treatment. J Exp Clin Cancer Res. 2011; 30:87. PMC: 3197541. DOI: 10.1186/1756-9966-30-87. View

4.
Sung H, Ferlay J, Siegel R, Laversanne M, Soerjomataram I, Jemal A . Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021; 71(3):209-249. DOI: 10.3322/caac.21660. View

5.
Hanna G, Patel N, Tedla S, Baugnon K, Aiken A, Agrawal N . Personalizing Surveillance in Head and Neck Cancer. Am Soc Clin Oncol Educ Book. 2023; 43:e389718. DOI: 10.1200/EDBK_389718. View